Exact Mass: 304.9721

Exact Mass Matches: 304.9721

Found 108 metabolites which its exact mass value is equals to given mass value 304.9721, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Isoimide

N-(Bromophenyl)-3,4,5,6-tetrahydroisophthalimide

C14H12BrNO2 (305.0051)

Imide

N-(4-Bromophenyl)-3,4,5,6-tetrahydrophthalimide

C14H12BrNO2 (305.0051)

2-Iodohippuric acid

2-{[hydroxy(2-iodophenyl)methylidene]amino}acetic acid

C9H8INO3 (304.9549)

2-Benzamido-2-iodoacetic acid

2-iodo-2-(phenylformamido)acetic acid

C9H8INO3 (304.9549)

m-Iodohippuric acid

2-[(3-iodophenyl)formamido]acetic acid

C9H8INO3 (304.9549)

AS-252424

5-[5-(4-fluoro-2-hydroxy-phenyl)-furan-2-ylmethylene]-thiazolidine-2,4-dione

C14H8FNO4S (305.0158)

Acetamide,2,2,2-trichloro-N-[3-(trifluoromethyl)phenyl]-

C9H5Cl3F3NO (304.9389)

Sodium risedronate

C7H10NNaO7P2 (304.983)

C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

10H-Phenothiazine,3,7-dinitro-, 5-oxide

C12H7N3O5S (305.0106)

5-Chloro-2-methyl-3-(3-sulfopropyl)benzothiazolium,inner salt

C11H12ClNO3S2 (304.9947)

4-(2-bromoacetyl)-N,N-dimethylbenzenesulfonamide

C10H12BrNO3S (304.9721)

4-Bromo-2-methoxy-N-phenylbenzamide

C14H12BrNO2 (305.0051)

2-Methyl-2-propanyl (2-bromo-4-chlorophenyl)carbamate

C11H13BrClNO2 (304.9818)

2-[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]aniline

C14H9Cl2N3O (305.0123)

3-Bromo-N-(tert-butyl)-5-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

5-(3-bromophenyl)thieno[2,3-d]pyrimidin-4-amine

C12H8BrN3S (304.9622)

5-Bromo-2-deoxycytidine

C9H12BrN3O4 (305.0011)

5-Bromo-N-cyclopropyl-2-methoxybenzenesulfonamide

C10H12BrNO3S (304.9721)

4-(PYRIDIN-4-YLOXY)BENZENE-1-SULFONYL CHLORIDE

C11H9Cl2NO3S (304.968)

BENZYL 4-BROMOPHENYLCARBAMATE

C14H12BrNO2 (305.0051)

(4-bromophenyl)-(3-nitrophenyl)methanone

C13H8BrNO3 (304.9688)

3-Ethyl-2-Methylbenzothiazolium Iodide

C10H12INS (304.9735)

2-Iodohippuric acid

C9H8INO3 (304.9549)

4-(2-PYRIDINYLOXY)BENZENESULFONYLCHLORIDEHYDROCHLORIDE

C11H9Cl2NO3S (304.968)

ETHYL 3-(5-BROMO-2-METHYL-4-NITRO-1H-IMIDAZOL-1-YL)PROPANOATE

C9H12BrN3O4 (305.0011)

3-bromo-7-pyridin-3-ylthieno[3,2-c]pyridin-4-amine

C12H8BrN3S (304.9622)

N-CHLOROACETYL-3,5-BIS(TRIFLUOROMETHYL)ANILINE

C10H6ClF6NO (305.0042)

2-BROMO-3-CHLOROPHENYL N,N-DIETHYLCARBAMATE

C11H13BrClNO2 (304.9818)

4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carbonyl chloride

C12H7ClF3NOS (304.9889)

4-[(3-Bromophenyl)sulfonyl]morpholine

C10H12BrNO3S (304.9721)

n-t-butyl 3-bromo-4-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

N-(4-bromophenyl)-4-methoxy-benzamide

C14H12BrNO2 (305.0051)

6-bromo-3-chloro-N-(oxan-4-ylmethyl)pyrazin-2-amine

C10H13BrClN3O (304.993)

7-BROMO-1,2,3,4-TETRAHYDRO-ACRIDINE-9-CARBOXYLICACID

C14H12BrNO2 (305.0051)

2-(4-methoxy-phenyl)-imidazo[1,2-a]pyrimidine monohydrobromine

C13H12BrN3O (305.0164)

ETHYL 2-[(4,5-DICHLORO-1H-IMIDAZOL-1-YL)METHYL]-1,3-THIAZOLE-4-CARBOXYLATE

C10H9Cl2N3O2S (304.9793)

1-(Phenylsulfonyl)pyrrole-3-sulfonyl chloride

C10H8ClNO4S2 (304.9583)

2-(bromomethyl)-1,3,5-trinitrobenzene

C7H4BrN3O6 (304.9283)

3-chloro-5-cyclopropyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid

C11H7ClF3N3O2 (305.0179)

2-Bromo-N-methyl-5-(trifluoromethoxy)aniline, HCl

C8H8BrClF3NO (304.943)

4-fluoro-2-iodo-5-(trifluoromethyl)benzenamine

C7H4F4IN (304.9325)

4-(2-bromophenyl)sulfonylmorpholine

C10H12BrNO3S (304.9721)

2-Bromo-N-pentylbenzenesulfonamide

C11H16BrNO2S (305.0085)

4-BROMO-3-METHOXY-N-PHENYLBENZAMIDE

C14H12BrNO2 (305.0051)

methyl 2-(4-iodoanilino)-2-oxoacetate

C9H8INO3 (304.9549)

ETHYL 2-CHLORO-2-(2-(4-CHLORO-2-NITROPHENYL)HYDRAZONO)ACETATE

C10H9Cl2N3O4 (304.997)

Acetamide,N-[4-(dihydroxyoxidostibino)phenyl]-

C8H10NO4Sb (304.9648)

3-(6-Bromopyridin-2-yl)-4-methyl-benzoic acid methyl ester

C14H12BrNO2 (305.0051)

Benzenamine,N,N-bis(2-bromoethyl)-

C10H13Br2N (304.9415)

[2-(5-BROMO-THIOPHEN-2-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER

C11H16BrNO2S (305.0085)

4-Bromo-6-methoxy-2-(trifluoromethyl)quinoline

C11H7BrF3NO (304.9663)

2,6-Dibromo-4-tert-butylaniline

C10H13Br2N (304.9415)

3-(2-Amino-4-pyrimidinyl)-6-bromo-1H-pyrrolo[2,3-b]pyridin-4-ol

C11H8BrN5O (304.9912)

tris(acetonitrile)tricarbonylmolybdenum

C9H9MoN3O3 (304.9698)

4-CYANO-3-(4-METHOXYPHENYL)-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLIC ACID

C14H11NO3S2 (305.018)

4-(Pyridin-3-yloxy)benzene-1-sulfonyl chloride hydrochloride

C11H9Cl2NO3S (304.968)

Methyl 2-(2-aminoethyl)-5-iodobenzoate

C10H12INO2 (304.9913)

Methyl 2-[(1S)-1-aminoethyl]-5-iodobenzoate

C10H12INO2 (304.9913)

Benzyl 2-amino-5-bromobenzoate

C14H12BrNO2 (305.0051)

methyl 4-(dimethylamino)-3-iodobenzoate

C10H12INO2 (304.9913)

5-[(4-CHLOROPHENYL)THIO]THIOPHENE-2-SULFONAMIDE

C10H8ClNO2S3 (304.9406)

BENZYL (2-IODOETHYL)CARBAMATE

C10H12INO2 (304.9913)

4-[(4-Bromphenyl)sulfonyl]morpholin

C10H12BrNO3S (304.9721)

5-(4-bromophenyl)thieno[2,3-d]pyrimidin-4-amine

C12H8BrN3S (304.9622)

2-(5-BROMO-THIOPHEN-2-YL)-2,3-DIHYDRO-BENZOFURAN-5-CARBONITRILE

C13H8BrNOS (304.951)

6-Bromo-4-methoxy-2-(trifluoromethyl)quinoline

C11H7BrF3NO (304.9663)

5-bromo-N-(tert-butyl)-2-Methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

2-(4-Chloro-3-nitrobenzoyl)benzoic acid

C14H8ClNO5 (305.0091)

5-Bromo-2-(3-methyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine

C10H7BrF3N3 (304.9775)

3-Bromo-N-butyl-5-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

3-Bromo-N-(tert-butyl)-N-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

4-Bromo-N-(tert-butyl)-3-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

2-Bromo-6-(3-methyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine

C10H7BrF3N3 (304.9775)

methyl 2-amino-4-ethyl-5-iodobenzoate

C10H12INO2 (304.9913)

Apoptosis Activator 2

C15H9Cl2NO2 (305.001)

3-bromo-N,N-diethyl-4-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

3-Bromo-N-cyclopropyl-4-methoxybenzenesulfonamide

C10H12BrNO3S (304.9721)

3-Bromo-N,N-diethyl-5-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

4-Bromo-N,N-diethyl-3-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)

2,6-Dibromo-4-butylaniline

C10H13Br2N (304.9415)

N-(6-Iodobenzo[D][1,3]Dioxol-5-Yl)Acetamide

C9H8INO3 (304.9549)

2-(2,6-DICHLOROBENZYL)THIAZOLE-4-CARBONYL CHLORIDE

C11H6Cl3NOS (304.9236)

N-BUTYL 3-BROMO-4-METHYLBENZENESULFONAMIDE

C11H16BrNO2S (305.0085)

3-Bromo-N-pentylbenzenesulfonamide

C11H16BrNO2S (305.0085)

7-Nitro-9-oxo-9H-fluorene-2-sulfonic acid

C13H7NO6S (304.9994)

4-Acetamido-3-iodobenzoic acid

C9H8INO3 (304.9549)

3-Iodo-4-(propylamino)benzoic acid

C10H12INO2 (304.9913)

4-Iodo-acetamido phenylboronic acid

C8H9BINO3 (304.972)

2,3-cyclic UMP(1-)

C9H10N2O8P- (305.0175)

A 2,3-cyclic nucleotide(1-) which is obtained from 2,3-cyclic UMP by removal of a proton from the cyclic phosphate group.

2-bromo-N-(3-methoxyphenyl)benzamide

C14H12BrNO2 (305.0051)

Iodohippuric acid i-131

C9H8INO3 (304.9549)

C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate

2-(2,3,3-Trichloro-1-nitroprop-2-enylidene)-1,3-dihydrobenzimidazole

C10H6Cl3N3O2 (304.9526)

5-((5-(4-Fluoro-2-hydroxyphenyl)furan-2-yl)methylene)thiazolidine-2,4-dione

C14H8FNO4S (305.0158)

5-[(1,3-Benzothiazol-2-ylthio)methyl]-2-furancarboxylic acid methyl ester

C14H11NO3S2 (305.018)

Iodohippuric acid I-125

C9H8INO3 (304.9549)

alpha-D-ribose 1-methylphosphonate 5-phosphate(3-)

C6H11O10P2-3 (304.9827)

Cyclic 35-uridine monophosphate

C9H10N2O8P- (305.0175)

2-(5-Bromo-2-furanyl)-6-methyl-3,1-benzoxazin-4-one

C13H8BrNO3 (304.9688)

4-Hydroxy-3-iodophenylpyruvate

C9H6IO4- (304.9311)

Taminadenant

C10H8BrN7 (305.0025)

Taminadenant (NIR178; PBF509) is a highly potent and orally active adenosine A2A receptor (A2AR) antagonist. Taminadenant can antagonize A2AR agonist-mediated cAMP accumulation and impedance responses with KB values of 72.8 nM and 8.2 nM, respectively. Taminadenant reverses motor impairments in several rat models of movement disorders, including catalepsy, tremor, and hemiparkinsonism. Taminadenant can also inhibit tumor growth when combined with Spartalizumab (HY-P9972). Taminadenant reactivate the antitumor immune response[1][2].